{"name":"Factor Therapeutics Ltd.","slug":"factor-therapeutics-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"VF001-DP HD","genericName":"VF001-DP HD","slug":"vf001-dp-hd","indication":"Other","status":"phase_2"},{"name":"VF001-DP LD","genericName":"VF001-DP LD","slug":"vf001-dp-ld","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"VF001-DP HD","genericName":"VF001-DP HD","slug":"vf001-dp-hd","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"VF001-DP LD","genericName":"VF001-DP LD","slug":"vf001-dp-ld","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxOT2kyejZveWFQLXAydUVZUlRtTlAyZW1NUHVneTZvNzF0X0w2cGt6WGlqOW9qRmp4c1RuNm1UZXVCUXctUk54SlFaT2RRdzZuTUFJVkRhRzNJVmVFOTJ2cEZBazU5ZUJvWElfNnhxWDVUc1VVSWxDRVdwNjRPTGRXTjFfVVdDa0FyU01SNklHR0xlX0hCcVBRdGZDcw?oc=5","date":"2026-04-08","type":"pipeline","source":"openPR.com","summary":"Key Strategic Factors and Emerging Trends Shaping the Acute - openPR.com","headline":"Key Strategic Factors and Emerging Trends Shaping the Acute","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxQTW40UE9WWk5DdlN2c2ZYc1NETmNycWVTQkFOV3ZtbWpELXhrN1I2Ul9NU3JEUlVTa21YLUpKN0g0MTNEWEU0Tm9PVDRrLXU2RTlpb0VaWEFLaTVyYndwZnkyZmtVOXVKeDhmNTd6SXNtSVNxRzZNZ1dwRUJsNmtkRXcxd2FkMzVsTUdmeHNtc2FsWWlKbU9XbTFzcw?oc=5","date":"2026-04-08","type":"pipeline","source":"openPR.com","summary":"Global Factors Influencing the Rapid Evolution of the Acute Migraine Treatment Market - openPR.com","headline":"Global Factors Influencing the Rapid Evolution of the Acute Migraine Treatment Market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxNSGRmZkFCWWo0SG8wRGdJUEczRkJocEtmT0w2elBMV2ZJZEhVUWlNbnVXTmJvMDRqTm5LbHFIWFZhZTZHejNLWlVFRGZfQUtWOW1XYV95aGdKd1kzR1RFd0luQmVjem5rZnBNMVlKM1NsSUp0UUJRRHp2c3V5N1RsNURnTjVSRlM2d3pvQ214Q0I?oc=5","date":"2026-04-08","type":"deal","source":"openPR.com","summary":"Emerging Growth Patterns Driving Rapid Expansion in the Acquired Hemophilia Treatment Market - openPR.com","headline":"Emerging Growth Patterns Driving Rapid Expansion in the Acquired Hemophilia Treatment Market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNSjdTc3ZUVnpWUExSNWYzdmtBZ01sOWtwMlFOTzVYUXp4Tk9FWXF5SGR6RUVqdFQ2bnlKeU53UGgzdHkyOG1Sc1VicTRyRHIxY2RVMS03NW53OWFvZEdTeXRUclhCWGtvNG04aTdBZktfV29GMFBLVDRlcjliSklaakVWMldjSzRKdC0wMHdxTWJxdDlsd1lMMnpiVEY?oc=5","date":"2026-04-08","type":"pipeline","source":"openPR.com","summary":"Global Factors Driving the Rapid Evolution of the Veterinary Autoimmune Disease Therapeutics Market - openPR.com","headline":"Global Factors Driving the Rapid Evolution of the Veterinary Autoimmune Disease Therapeutics Market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNSjVzUUZ0MEg2OVcxWnlpbkQ5c3pZVC1DenE3ZXZzTUgxNHFSVVhMb294NkVkMmpiMU9fNEtyaXhGQU9ROE9EQ2hNWDlfQTFySEtSdjV4LXkwMi0wZ0tfN0l2endvSEJxYWxLajV4cVVMRVJ0bW9MQWtCdUJ0eEo3dXZuNVZBMmF1T0RTQ1EzVlVKUWoxM2c?oc=5","date":"2026-03-16","type":"pipeline","source":"Fortune Business Insights","summary":"Pharmaceuticals Market Size, Share, Industry Analysis, 2034 - Fortune Business Insights","headline":"Pharmaceuticals Market Size, Share, Industry Analysis, 2034","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE9KbGVtTWF4dHR0M25KNWpGNWtyVldSTFB5ZnB3UkNTbTRzN1Fobk02MTRyM01EZ08tR3JTc2w1ZlBTYUpScGdKcVFvLVVjMC1ueXVHaWhCVzhEX0JETEdnMjh4ejBwc1ZVdlFPNThvMnJkT2VRWnJ1TERrNEptRUE?oc=5","date":"2026-02-18","type":"pipeline","source":"Yahoo Finance","summary":"The China factor: US pharma group campaigns for increased competitiveness - Yahoo Finance","headline":"The China factor: US pharma group campaigns for increased competitiveness","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNMlJXMF9Wd1o4RGZxSkVJVHA5Z1VYNkFrR3NrWDNiOExrYTFsamI1a1VYXzQwUmpxcHBnYkxheWl1eWtpZ3RrYUtMYmh5WTFjRDctTlJqcEFjQ0p1NHZhZ0NwTlFkb2Z4RmxVa2tHYUpfVC10cHVYeVBnUVNpOTFfTkdHT1c4TzJvNWU1WUYwa3NwV1lvNmo1WHNFSUl3ZFYxQmp6MDViN0w?oc=5","date":"2025-11-19","type":"pipeline","source":"Fierce Biotech","summary":"Tempest turns to Factor for lifeline, trading majority stake for CAR-Ts and CEO - Fierce Biotech","headline":"Tempest turns to Factor for lifeline, trading majority stake for CAR-Ts and CEO","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-11-13","type":"earnings","source":"simplywall.st","summary":"We Think Shareholders Should Be Aware Of Some Factors Beyond Jagsonpal Pharmaceuticals' (NSE:JAGSNPHARM) Profit - simplywall.st","headline":"We Think Shareholders Should Be Aware Of Some Factors Beyond Jagsonpal Pharmaceuticals' (NSE:JAGSNPHARM) Profit","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE56aDQ1elM2bGlkWTFtY09zd1BzSW1wYlpMY1IyNjZubzN4ZjBXUDcwdjgyTnpIREcwLTd1eXRtUElKNWhyOWhtQjMtMTBsQVduT3paT1FteW01S1RnWkg4?oc=5","date":"2025-10-14","type":"pipeline","source":"Nature","summary":"Big pharma seduced by transcription factors again. What has changed? - Nature","headline":"Big pharma seduced by transcription factors again. What has changed?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxPcTl2NEVKQllHaUQwMkRMLTFWdHRhOGh6VjhzMFpTaDlKcEQ1aWdMRmpTRDROQXM2dEhTWTRGNFBheFlwbkxFWkNnejByLWdGUEx3VnpFUkxzWTlCbjdlaU81SndqTF9GZTk2OU9iUGk5eHdYU2JyUWN4VzBaTy1va3diSWtseUFqSEJNRWVlYVJnNWNWSDFaUkN3bFlWY2RzZW1acE1pUQ?oc=5","date":"2025-09-15","type":"deal","source":"Jacksonville Daily Record","summary":"Cadrenal Therapeutics acquires eXIthera Pharmaceuticals - Jacksonville Daily Record","headline":"Cadrenal Therapeutics acquires eXIthera Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAJBVV95cUxNRTdveUxUa3NKWnJFeGd4eW4xTUJqTHh3czJ5WDBHYVZ2dlhPZUtIanR0ZkRTcElCd2NESERPek8yQ2g0c05uLTdGNFF2SVBPajFDbGpFXzRpSWI3djRVWXROdnI1QTlUcW1nUWZScE5qQmNna3NNeDUyYU5hckxtMnlpN3BBNEk3d0lpQ3JMQ05INkxVRklQTm1xU013WHdGS1NwYjJVQnl2bm8zZjIzUnFFaHBCeFZwYm1yY2hJT29KS0FPbnZuamMwcEhBZFRta04tVmxFLXhGb0dnaEdsX0dLZ3kzRXJ0NWpJQXEtOWxsQTl5TGxBQ2FsSHFfQmxlaXZ6d0dKNUhZMXQ1eWZSZXRsN0ttRTlU?oc=5","date":"2025-08-06","type":"pipeline","source":"PR Newswire","summary":"Intas Pharmaceuticals and Accord BioPharma Become One of the Largest Global Suppliers of Pegfilgrastim with Acquisition of UDENYCA® - PR Newswire","headline":"Intas Pharmaceuticals and Accord BioPharma Become One of the Largest Global Suppliers of Pegfilgrastim with Acquisition ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQazFLcVVxN3I4cWJIWVJ5VWtOX210eC1ESVNXbTJ4cDVfS2VrU3ZWOTlMeUZ6ZWVlYUFJbmJVZllrcWFzZ1VHVlQ2a05TbjI2V2ZZaUk5NEwxYXAyMDVvV3U0ZktIeFlXVnE0ZG1yT3BadHd0RExZSWJWY0ZnUjFLNjFucS1RazlQajQ2QkdTVkVuWDRhT0dHTm9BSkhZbkp1YUstYnFkRTY?oc=5","date":"2025-04-11","type":"pipeline","source":"Fierce Pharma","summary":"As Pfizer backs out of hemophilia gene therapy space, CSL hopes Hemgenix is here to stay - Fierce Pharma","headline":"As Pfizer backs out of hemophilia gene therapy space, CSL hopes Hemgenix is here to stay","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":2},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}